Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04105842
Other study ID # 41251
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 23, 2019
Est. completion date July 28, 2022

Study information

Verified date June 2023
Source University of Waterloo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to refit habitual wearers of daily disposable contact lenses who currently experience symptoms of dry eye and discomfort during lens wear with a different type of daily disposable contact lens. Ocular signs and symptoms of dry eye will be assessed following the guidelines outlined by the Tear Film and Ocular Surface Society (TFOS) in the Dry Eye Workshop II (DEWS II). The performance of the habitual contact lenses and the study lenses will be determined using different optometric assessments. Study lenses will be worn for one month following a daily disposable wear schedule.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date July 28, 2022
Est. primary completion date July 28, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 17 Years and older
Eligibility Inclusion Criteria: 1. Is at least 17 years of age and has full legal capacity to volunteer; 2. Has read and signed an information consent letter; 3. Is willing and able to follow instructions and maintain the appointment schedule; 4. As per TFOS DEWS II, have dry eye symptoms (without CL wear) as determined by an OSDI score of =13 and at least one of the following: 1. Tear osmolarity = 308mOsm/L or interocular difference >8 mOsm/L 2. Non-invasive tear breakup time of < 10 seconds in at least one eye 3. More than 5 spots of corneal staining OR > 9 conjunctival spots in at least one eye 5. Reports dryness while wearing DD CLs with CLDEQ-8 score = 12 and = 203 6. Habitually wears soft spherical DD CLs with a power between +6.00D and -10.00D 7. Manifest spectacle cyl =1.00DC in either eye 8. BCVA =0.20 log MAR each eye with habitual & DT1 9. Acceptable fit with habitual & DT1 10. Willing to wear DT1 CLs at least 3 days per week and 6 hours per day throughout the study Exclusion Criteria: 1. Is participating in any concurrent clinical or research study; 2. Has any known active* ocular disease and/or infection; 3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable; 4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study; 6. Is pregnant, lactating or planning a pregnancy at the time of enrolment (by self-report); 7. Is aphakic; 8. Has undergone refractive error surgery; 9. Has taken part in another clinical research study within the last 14 days; 10. Current habitual wearer of DT1 11. Any ocular and/or systemic conditions or concomitant medication to contraindicate contact lens wear or be expected to interfere with the primary outcome variables. - For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.

Study Design


Intervention

Device:
Delfilcon A
Participants wear delafilcon A contact lenses on a daily disposable basis.

Locations

Country Name City State
Canada Centre for Ocular Research & Education Waterloo Ontario

Sponsors (2)

Lead Sponsor Collaborator
University of Waterloo Alcon Research

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 1 after screening with habitual lenses
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 3 after screening with habitual lenses
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 5 after screening with habitual lenses
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). 1-week follow up with habitual lens
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 1 after dispense with delefilcon A
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 3 after dispense with delefilcon A
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 5 after dispense with delefilcon A
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 7 after dispense with delefilcon A
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 21 after dispense with delefilcon A
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). Day 28 after dispense with delefilcon A
Primary Subjective Comfort at End of Day With Contact Lens Wear Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). 1-month follow up with delefilcon A
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 1 after screening with habitual lenses
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 3 after screening with habitual lenses
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 5 after screening with habitual lenses
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). 1-week follow up with habitual lens
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 1 after dispense with delefilcon A
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 3 after dispense with delefilcon A
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 5 after dispense with delefilcon A
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 7 after dispense with delefilcon A
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 21 after dispense with delefilcon A
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). Day 28 after dispense with delefilcon A
Primary Subjective Rating of End of Day Dryness With Contact Lens Wear Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). 1-month follow up with delefilcon A
Primary Average Lens Wear Time Average lens wear time is recorded Day 1 after screening with habitual lenses
Primary Average Lens Wear Time Average lens wear time is recorded Day 3 after screening with habitual lenses
Primary Average Lens Wear Time Average lens wear time is recorded Day 5 after screening with habitual lenses
Primary Average Lens Wear Time Average lens wear time is recorded 1-week follow up with habitual lens
Primary Average Lens Wear Time Average lens wear time is recorded Day 1 after dispense with delefilcon A
Primary Average Lens Wear Time Average lens wear time is recorded Day 3 after dispense with delefilcon A
Primary Average Lens Wear Time Average lens wear time is recorded Day 5 after dispense with delefilcon A
Primary Average Lens Wear Time Average lens wear time is recorded Day 7 after dispense with delefilcon A
Primary Average Lens Wear Time Average lens wear time is recorded Day 21 after dispense with delefilcon A
Primary Average Lens Wear Time Average lens wear time is recorded Day 28 after dispense with delefilcon A
Primary Average Lens Wear Time Average lens wear time is recorded 1-month follow up with delefilcon A
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 1 after screening with habitual lenses
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 3 after screening with habitual lenses
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 5 after screening with habitual lenses
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) 1-week follow up with habitual lens
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 1 after dispense with delefilcon A
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 3 after dispense with delefilcon A
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 5 after dispense with delefilcon A
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 7 after dispense with delefilcon A
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 21 after dispense with delefilcon A
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) Day 28 after dispense with delefilcon A
Primary Comfortable Lens Wear Time Comfortable lens wear time (Time of discomfort - Time of insertion) 1-month follow up with delefilcon A
See also
  Status Clinical Trial Phase
Completed NCT05027087 - The Effect of a Novel Blueberry Supplement on Dry Eye Disease Phase 3
Completed NCT05102409 - An Exploratory Clinical Trial to Assess Safety and Tolerability in Subjects With Dry Eye Disease Phase 2
Completed NCT06159569 - Performance and Tolerability of the Medical Device LACRIACT N/A
Completed NCT04081610 - Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution Phase 1
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT05825599 - PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms N/A
Completed NCT03418727 - Dry Eye Disease Study With Brimonidine Phase 2
Active, not recruiting NCT04425551 - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction N/A
Recruiting NCT04527887 - Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED) Phase 4
Not yet recruiting NCT06379685 - Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface. Phase 1
Active, not recruiting NCT05618730 - Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B Phase 1
Completed NCT04553432 - Dry Eye OmniLenz Application of Omnigen Research Study Phase 4
Recruiting NCT04109170 - Dry Eye Evaluation System Based on Bioinformatics
Completed NCT05505292 - Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers Phase 4
Completed NCT04668131 - Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease N/A
Completed NCT06176651 - Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers Phase 4
Not yet recruiting NCT02218827 - Topical Steroid Treatment For Dry Eye N/A
Completed NCT02235259 - Efficacy and Safety of XG-104 for the Treatment of Dry Eye Phase 2
Completed NCT01959854 - Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye N/A
Completed NCT01718028 - The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects N/A